Overview

A Study Comparing IOP-Lowering Treatments to Bimatoprost in Patients With Primary Open Angle Glaucoma or Ocular Hypertension

Status:
Completed
Trial end date:
2013-04-01
Target enrollment:
Participant gender:
Summary
An observational study comparing changing from an IOP-lowering treatment to a bimatoprost-containing IOP treatment in primary open-angle glaucoma (POAG) or ocular hypertension (OHT). Visits and treatment are per normal clinical practice.
Details
Lead Sponsor:
Allergan
Treatments:
Bimatoprost